Explore
Validate
LearnABIN1003158
antibody from antibodies-online
Targeting: SLPI
ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1003158 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Secretory Leukocyte Peptidase Inhibitor (SLPI) antibody
- Antibody type
- Polyclonal
- Antigen
- SLPI antibody was raised in rabbits against a 17 amino acid peptide from near the center of human SLPI.
- Description
- Affinity chromatography purified via peptide column.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- 4°C
- Handling
- Antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. During shipment, small volumes of antibody will occasionally become entrapped in the seal of the product vial. For products with volumes of 200 myl or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container?s cap.
Submitted references Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.
Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics.
Expression of the secretory leukoprotease inhibitor gene in epithelial cells.
Jana NK, Gray LR, Shugars DC
Journal of virology 2005 May;79(10):6432-40
Journal of virology 2005 May;79(10):6432-40
Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.
Taggart CC, Cryan SA, Weldon S, Gibbons A, Greene CM, Kelly E, Low TB, O'neill SJ, McElvaney NG
The Journal of experimental medicine 2005 Dec 19;202(12):1659-68
The Journal of experimental medicine 2005 Dec 19;202(12):1659-68
Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics.
Hiemstra PS, Fernie-King BA, McMichael J, Lachmann PJ, Sallenave JM
Current pharmaceutical design 2004;10(23):2891-905
Current pharmaceutical design 2004;10(23):2891-905
Expression of the secretory leukoprotease inhibitor gene in epithelial cells.
Abe T, Kobayashi N, Yoshimura K, Trapnell BC, Kim H, Hubbard RC, Brewer MT, Thompson RC, Crystal RG
The Journal of clinical investigation 1991 Jun;87(6):2207-15
The Journal of clinical investigation 1991 Jun;87(6):2207-15
No comments: Submit comment
No validations: Submit validation data